Related Experiment Video
Updated: May 21, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Personalized prediction of psoriasis relapse post-biologic discontinuation: a machine learning-driven population
Shan Huang1, Yanping Bai2, Ruozhou Qi1
1Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Predicting psoriasis relapse after stopping biologics is now possible with a new model. This tool uses clinical data to guide personalized treatment strategies and reduce disease burden.
Area of Science:
- Dermatology
- Clinical Research
- Predictive Modeling
Background:
- Psoriasis relapse after biologic discontinuation poses a significant challenge.
- Optimizing treatment strategies can reduce relapse rates and disease burden.
Purpose of the Study:
- To develop and validate a personalized prediction model for psoriasis relapse.
- Aid in optimizing treatment strategies for patients discontinuing biologics.
Main Methods:
- Utilized Boruta algorithm and multivariate Cox regression to identify relapse predictors.
- Developed a nomogram and online calculator for outcome visualization and computation.
- Assessed model performance using ROC curves, AUC, C-statistics, calibration plots, and DCA.
Main Results:
- Included 597 patients (534 derivation, 63 validation).
- Identified anxiety, disease duration, prior/treatment duration, time to PASI 75, and max PASI as key predictors.
- Model demonstrated good predictive accuracy in internal and external validation.
Conclusions:
- A multivariate model using clinical data can predict psoriasis relapse risk post-biologic discontinuation.
- The model supports personalized treatment strategies for managing psoriasis.
More Related Videos
02:28Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018